Pfizer, Bristol-Myers Thinner Tops Warfarin for Strokes

Pfizer, Bristol-Myers Thinner Tops Warfarin for Strokes

Jun. 23, 2011
June 23 (Bloomberg) -- Pfizer Inc.'s and Bristol-Myers Squibb Co.'s experimental blood thinner apixaban prevented more strokes with less major bleeding than traditional treatment in patients with irregular heartbeats in a key study. Shannon Pettypiece reports on Bloomberg Television's "In the Loop." (Source: Bloomberg)
Bloomberg
Correction: Clarification: